Kidney transplant in black recipients: Are African Europeans different from African Americans?

American Journal of Transplantation

Volumn 5, Issue 11, 2005, Pages 2682-2687

  Pallet, Nicolas ^a   Thervet, Eric ^a   Alberti, Corinne ^b   Emal Aglaé, Violaine ^c   Bedrossian, Janine ^a   Martinez, Frank ^a   Roy, Carine ^b   Legendre, Christophe ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c Service de Néphrologie   (France)

Author keywords

African Americans; Graft survival; Renal transplantation

Indexed keywords

CREATININE; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; AFRICAN EUROPEAN; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; ETHNOLOGY; FEMALE; FRANCE; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HLA MATCHING; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; ISCHEMIA; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; COMPARATIVE STUDY; ETHNIC GROUP; MIDDLE AGED; MORTALITY; PHYSIOLOGY; SURVIVAL; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 33644796555     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01057.x     Document Type: Article

References (39)

1. Geiger HJ. Race and health care - an American dilemma¿ N Engl J Med 1996 335: 815 816.
2. Qualheim RE Rostand SG Kirk KA Rutsky EA Luke RG. Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis 1991 18: 336 343.
3. Rostand SG. US minority groups and end-stage renal disease: a disproportionate share. Am J Kidney Dis 1992 19: 411 413.
4. Renal Data System USRDS 1996 Annual Data Report. Bethesda, MD, USA: National Institute of Diabetes and Digestive and Kidney Diseases, 1996.
5. Opelz G Mickey MR Terasaki PI. Influence of race on kidney transplant survival. Transplant Proc 1977 9: 137 142.
6. Curtis JJ. Kidney transplantation: racial or socioeconomic disparities¿ Am J Kidney Dis 1999 34: 756 758.
7. Isaacs RB Nock SL Spencer CE et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999 34: 706 712.
8. OPTN-SRTR 2003 Annual Report. Available at: http://www.optn.org.
9. Young CJ Gaston RS. Renal transplantation in black Americans. N Engl J Med 2000 343: 1545 1552.
10. Lindholm A Welsh M. Alton C Kahan BD. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability. Clin Pharmacol Ther 1992 52: 359 371.
11. David RJ Collins JW Jr.. Differing birth weight among infants of U.S.-born blacks, African-born blacks, and U.S.-born whites. N Engl J Med 1993 337: 1209 1214.
12. First MR Schroeder TJ Monaco AP Simpson MA Curtis JJ Armenti VT. Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation subpopulations. Clin Transplant 1996 10: 55 59.
13. Neylan JF. Immunosuppressive therapy in high-risk transplant patients: dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1997 64: 1277 1282.
14. Neylan JF. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. Transplantation 1998 65: 515 523.
15. Cosio FG Dillon JJ Falkenhain ME et al. Racial differences in renal allograft survival: the role of systemic hypertension. Kidney Int 1995 47: 1136 1141.
16. Kasiske BL Snyder JJ Gilbertson D Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3: 178 185.
17. Basadonna GP Matas AJ Gillingham KJ et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993 55: 993 995.
18. Posner MP McGeorge MB Mendez-Picon G Mohanakumar T Lee HM. The importance of the Lewis system in cadaver renal transplantation. Transplantation 1986 41: 474 477.
19. Butkus DE Dottes AL Meydrech EF Barber WH. Effect of poverty and other socioeconomic variables on renal allograft survival. Transplantation 2001 72: 261 266.
20. Sanders CE Curtis JJ Julian BA et al. Tapering or discontinuing cyclosporine for financial reasons - a single-center experience. Am J Kidney Dis 1993 21: 9 15.
21. Yen EF Hardinger K Brennan DC et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004 4: 1703 1708.
22. Adams J Ward RH. Admixture studies and the detection of selection. Science 1973 180: 1137 1143.
23. Chakraborty R Kamboh MI Ferrell RE. 'Unique' alleles in admixed populations: a strategy for determining 'hereditary' population differences of disease frequencies. Ethn Dis 1991 1: 245 256.
24. Glass B Li CC. The dynamics of racial intermixture - an analysis based on the American Negro. Am J Hum Genet 1953 5: 1 20.
25. Reed TE. Caucasian genes in American Negroes. Science 1969 165: 762 768.
26. Cockcroft RW Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16: 31 41.
27. Butkus DE Meydrech MF Raju SS. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992 327: 840 845.
28. Kasiske BL Neylan JF III. Riggio RR et al. The effect of race on access and outcome in transplantation. N Engl J Med 1991 324: 302 307.
29. Cecka JM. The UNOS Scientific Renal Transplant Registry. In: Cecka JM Terasaki PI, eds. Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 1 16.
30. Gaston RS Hudson SL Deierhoi MH et al. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression. Transplantation 1992 53: 103 109.
31. Kerman RH Kimball PM Van Buren CT Lewis RM Kahan BD. Possible contribution of pretransplant immune responder status to renal allograft survival differences of blacks versus white recipients. Transplantation 1991 51: 338 42.
32. Thervet E Anglicheau D King B et al. Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation 2003 76: 1233 1235.
33. Oriol R Le Pendu J Chun C. Influence of the original disease, race, and center on the outcome of kidney transplantation. Transplantation 1982 33: 22 26.
34. Terasaki PI Cecka JM Gjertson DW Takemoto S Cho YW Yuge J. Risk rate and long-term kidney transplant survival. In: Cecka JM Terasaki PI, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997: 443 458.
35. De Geest S Borgermans L Gemoets H et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995 59: 340 347.
36. Gornick ME Eggers PW Reilly TW et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med 1996 335: 791 799.
37. Woodward RS Schnitzler MA Lowell JA et al. Medicare's extended immunosuppression coverage improved graft survival (abstract). J Am Soc Nephrol 1999 10: 751A.
38. Sanders CE Julian BA Gaston RS Deierhoi MH Diethelm AG Curtis JJ. Benefits of continued cyclosporine through an indigent drug program. Am J Kidney Dis 1996 28: 572 577.
39. Chakkera HA O'Hare AM Johansen KL et al. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol 2005 16: 269 277.